Skip to content
Hypercell Technologies logo — Elevating food safety. Redefining standards.

Hypercell Technologies

Elevating food safety. Redefining standards.

Founded 2021 United States United States 8 employees Seed Total: $1.00M Biotechnology, Life Sciences

General Information

Company Name Hypercell Technologies
Founded Year 2021
Location United States United States
Employees 8
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Hypercell Technologies. To contact Hypercell Technologies, visit hypercelltechnologies.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hypercell Technologies compare?

A PDF of Hypercell Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hypercell Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hypercell Technologies

Hypercell Technologies is a biotechnology startup based in the United States, founded in 2021. The company's slogan, "Elevating food safety. Redefining standards," reflects its core mission to address the critical issue of biological contamination in the food chain.

Hypercell's innovative approach involves a patented, on-premise molecular diagnostic that offers rapid and accurate results, eliminating the need for expensive equipment, laboratory facilities, or highly trained operators. This technology has the potential to revolutionize food safety protocols, providing food operators with a reliable method to assess contamination levels in less than an hour, comparable to the accuracy of gold standard PCR tests.

Despite advancements in the industry, the prevalence of food borne illnesses affecting 45 million Americans annually underscores the urgency for improved safety measures. Hypercell's solution addresses a critical gap in current testing methods, where rapid tests lack accuracy and more sensitive tests entail prolonged waiting periods for results.

The latest milestone for Hypercell was its Seed Round investment on 02 April 2024, with funding secured from Plug and Play. This support not only signifies confidence in the startup's technology but also indicates potential for further advancements in the biotechnology and life sciences sectors. Hypercell's commitment to enhancing food safety standards aligns with the growing emphasis on addressing public health concerns, positioning the company as an influential player in the evolving landscape of food safety technology.

Business keywords: Food safety, Biological contamination management, Molecular diagnostics, Pathogen testing, Infectious disease control, Animal reservoir management

Services & Products

Rapid point-of-care diagnostics for the food chain

Target Customers

Food production and transformation industry healthcare professionals food safety regulatory authorities

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Plug and Play
02 Apr 2024
Grant $1.00M 1
Grow-NY
15 Nov 2023
Seed Round Undisclosed 2
SOSV, indiebio
14 Nov 2023

Hypercell Technologies Alternatives & Competitors

View All Alternatives
Hypercell Technologies vs

Supporting biomedical research through serological testing services and kits.

8 employees
Biotechnology, Health Care
Hypercell Technologies vs

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Venture round
60 employees
Biotechnology, Health Care
Hypercell Technologies vs

Improving health worldwide through accurate, fast and affordable diagnostic testing

Grant
28 employees
Biotechnology, Health Care

FAQ About Hypercell Technologies

Elevating food safety. Redefining standards.
Hypercell Technologies was founded in 2021.
Hypercell Technologies is headquartered in United States.
Hypercell Technologies operates in Biotechnology and Life Sciences. Its work centres on Food safety, Biological contamination management, Molecular diagnostics and Pathogen testing. Its customers include Food production and transformation industry, healthcare professionals and food safety regulatory authorities.
Hypercell Technologies has approximately 8 employees.
Hypercell Technologies has completed 3 funding rounds, raising a total of $1.00M. The latest funding stage is Seed.
Hypercell Technologies offers: Rapid point-of-care diagnostics for the food chain.
Top alternatives and competitors to Hypercell Technologies include Intuitive Biosciences, Applied BioCode, Inc., Sherlock Biosciences, Biomode SA, INDICAL BIOSCIENCE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hypercell Technologies and Intuitive Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hypercell Technologies, https://www.bouncewatch.com/company/hypercell-technologies, updated 24 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout